Company news
Replimune Group, Inc. news in 2022
Replimune Group, Inc.'s news releases, calls and decks from 2022, newest first.
Replimune Announces Pricing of Public Offering
December 7, 2022
Replimune Enters into Clinical Collaboration Agreement with Roche for the Development of RP3 In Colorectal Cancer and Hepatocellular Carcinoma
December 6, 2022
Replimune Announces Positive Initial Data from the Anti-PD1 Failed Melanoma Cohort of the IGNYTE Clinical Trial & an RP2/3 Program Update
December 6, 2022
Replimune to Present at the Piper Sandler 34th Annual Healthcare Conference
November 22, 2022
Replimune to Host Virtual Investor Event on December 7, 2022
November 21, 2022
Replimune Reports Fiscal Second Quarter Financial Results and Provides Corporate Update
November 2, 2022
Replimune Secures $200 Million in Non-Dilutive Debt Financing from Hercules Capital, Inc.
October 6, 2022
Replimune Reports Fiscal First Quarter Financial Results and Provides Corporate Update
August 3, 2022
Replimune Announces the Departure of Jason Rhodes from its Board of Directors
June 2, 2022
Replimune to Present at the Jefferies Healthcare Conference
June 1, 2022
Replimune To Present at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting
May 25, 2022
Replimune Reports Fiscal Fourth Quarter and Year-Ended 2022 Financial Results and Provides Corporate Update
May 18, 2022
Replimune Provides New Clinical Data, Broad Program Update and Future Development Strategy for its Tumor-Directed Oncolytic Immunotherapies
March 29, 2022
Replimune to Host Virtual Investor Event on March 30, 2022
March 20, 2022
Replimune to Present at the 11th Annual SVB Leerink Global Healthcare Conference
February 10, 2022
Replimune Reports Third Fiscal Quarter Financial Results and Provides Corporate Update
February 2, 2022
Replimune Announces the Departure of Dr. Otello Stampacchia from its Board of Directors
January 30, 2022
Replimune Provides 2021 Year End Review and Overview of Expected 2022 Milestones
January 9, 2022
Replimune to Present at the 40th Annual J.P. Morgan Healthcare Conference
January 3, 2022